Works by Hara, Tomoko

Results: 49
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00170-7
    By:
    • Yoshizawa, Takahiro;
    • Uchibori, Ken;
    • Araki, Mitsugu;
    • Matsumoto, Shigeyuki;
    • Ma, Biao;
    • Kanada, Ryo;
    • Seto, Yosuke;
    • Oh-hara, Tomoko;
    • Koike, Sumie;
    • Ariyasu, Ryo;
    • Kitazono, Satoru;
    • Ninomiya, Hironori;
    • Takeuchi, Kengo;
    • Yanagitani, Noriko;
    • Takagi, Satoshi;
    • Kishi, Kazuma;
    • Fujita, Naoya;
    • Okuno, Yasushi;
    • Nishio, Makoto;
    • Katayama, Ryohei
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Utility of a rapid assay for prostaglandin E-major urinary metabolite as a biomarker in pediatric ulcerative colitis.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37145-6
    By:
    • Hagiwara, Shin-ichiro;
    • Abe, Naoki;
    • Hosoi, Kenji;
    • Hara, Tomoko;
    • Ishige, Takashi;
    • Shimizu, Hirotaka;
    • Mizuochi, Tatsuki;
    • Kakiuchi, Toshihiko;
    • Kunisaki, Reiko;
    • Matsuoka, Ryo;
    • Kondou, Hiroki;
    • Kakuta, Fumihiko;
    • Nakayama, Yoshiko;
    • Kimura, Takeshi;
    • Maeyama, Takatoshi;
    • Honma, Hitoshi;
    • Hirano, Daishi;
    • Saruta, Masayuki;
    • Yoshida, Tsutomu;
    • Okayasu, Isao
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38

    Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21396-w
    By:
    • Mizuta, Hayato;
    • Okada, Koutaroh;
    • Araki, Mitsugu;
    • Adachi, Jun;
    • Takemoto, Ai;
    • Kutkowska, Justyna;
    • Maruyama, Kohei;
    • Yanagitani, Noriko;
    • Oh-hara, Tomoko;
    • Watanabe, Kana;
    • Tamai, Keiichi;
    • Friboulet, Luc;
    • Katayama, Kazuhiro;
    • Ma, Biao;
    • Sasakura, Yoko;
    • Sagae, Yukari;
    • Kukimoto-Niino, Mutsuko;
    • Shirouzu, Mikako;
    • Takagi, Satoshi;
    • Simizu, Siro
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11496-z
    By:
    • Katayama, Ryohei;
    • Seto, Yosuke;
    • Oh-hara, Tomoko;
    • Koike, Sumie;
    • Gong, Bo;
    • Shimizu, Yuki;
    • Fujita, Naoya;
    • Togashi, Noriko;
    • Miyamoto, Masaya;
    • Kiga, Masaki;
    • Iwasaki, Shiho;
    • Kamai, Yasuki;
    • Tominaga, Yuichi;
    • Takeda, Yasuyuki;
    • Kagoshima, Yoshiko;
    • Watanabe, Kengo;
    • Isoyama, Takeshi;
    • Nakao, Naoki;
    • Hanzawa, Hiroyuki;
    • Yoda, Satoshi
    Publication type:
    Article